Subcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell Disorders

by | Jul 23, 2025 | Clinical Trials | 0 comments

​ Conditions: Plasma Cell Disorder

Interventions: Drug: Daratumumab Injection

Sponsors: University of Maryland, Baltimore; Johnson & Johnson

Not yet recruiting Conditions: Plasma Cell Disorder
Interventions: Drug: Daratumumab Injection
Sponsors: University of Maryland, Baltimore; Johnson & Johnson
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *